A one day meeting specifically aimed at the Scottish audience, where highlights will be presented from the ASH meeting.
The aim of this day event is to provide an overview of the breakthrough clinical data at ASH that will be useful for a Scottish audience. Many haematologists will not have the benefit of attending ASH so we anticipate this will be a highly popular event to hear from the expert faculty for malignant haematology disease areas.
Sessions to include: Myeloma, CLL , Myeloproliferative Neoplasms, Acute Myeloid Leukaemia, ALL - An Update on What's New, High Grade Lymphoma, Low Grade Lymphoma
Direct email queries to: [email protected]
